These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Vasoactive mediators in pregnancy-induced hypertensive disorders: a longitudinal study. Paarlberg KM, de Jong CL, van Geijn HP, van Kamp GJ, Heinen AG, Dekker GA. Am J Obstet Gynecol; 1998 Dec; 179(6 Pt 1):1559-64. PubMed ID: 9855596 [Abstract] [Full Text] [Related]
14. [Prostaglandin E2, F2 alpha,6-keto-prostaglandin F1 alpha and thromboxane B2 in the placenta of normotensive women and women with pregnancy induced hypertension]. Gao J. Zhonghua Fu Chan Ke Za Zhi; 1989 Nov; 24(6):331-3, 380. PubMed ID: 2632162 [Abstract] [Full Text] [Related]
15. Urinary excretion of thromboxane and prostacyclin metabolites during chronic low-dose aspirin: evidence for an extrarenal origin of urinary thromboxane B2 and 6-keto-prostaglandin F1 alpha in healthy subjects. Chiabrando C, Rivoltella L, Martelli L, Valzacchi S, Fanelli R. Biochim Biophys Acta; 1992 Feb 03; 1133(3):247-54. PubMed ID: 1737057 [Abstract] [Full Text] [Related]
16. Plasma thromboxane and prostacyclin: comparison during normal pregnancy and pregnancy complicated by hypertension. Ogino M, Abe Y, Jimbo T, Okahara T. Endocrinol Jpn; 1986 Apr 03; 33(2):197-202. PubMed ID: 3530728 [Abstract] [Full Text] [Related]
19. Hypertensive and normal pregnancy: a longitudinal study of blood pressure, distensibility of dorsal hand veins and the ratio of the stable metabolites of thromboxane A2 and prostacyclin in plasma. Smith AJ, Walters WA, Buckley NA, Gallagher L, Mason A, McPherson J. Br J Obstet Gynaecol; 1995 Nov 03; 102(11):900-6. PubMed ID: 8534627 [Abstract] [Full Text] [Related]